查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1689714

黏附包装：市场占有率分析、行业趋势和成长预测（2025-2030 年）

Adherence Packaging - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
出版日期: | 出版商: Mordor Intelligence | 英文 120 Pages | 商品交期: 2-3个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

黏性包装市场规模预计在 2025 年为 11.1 亿美元，预计到 2030 年将达到 15.4 亿美元，预测期内（2025-2030 年）的复合年增长率为 6.72%。

黏附包装市场-IMG1

关键亮点

  • 依从性包装主要用于医疗保健领域，可以简化药物管理，取代传统的锭剂笔记本。这种包装适合患者的日常生活，使他们能够按照医疗保健提供者的指示及时准确地服用处方笺。
  • 对于慢性阻塞性肺病(COPD) 的患者来说，药物治疗和疾病管理依从性差是导致紧急住院的一个已知因素。因此，对黏性包装的需求正在上升，预计在不久的将来会大幅增长。
  • 此外，越来越注重减少药物浪费正在加强依从性包装领域。废弃物不仅给医疗保健财务带来压力，也带来环境风险。然而，该行业面临挑战，尤其是高昂的实施、安装和维护成本，这可能会阻碍全球扩张。
  • 包装技术的最新进展整合了使用近距离场通讯(NFC) 和无线射频识别 (RFID) 的数位撷取功能。这些创新旨在加强检验过程。单位剂量泡壳包装具有被动、主动和互动元素，在应对鸦片类药物危机和提高用药安全性方面处于领先地位。被动元素包括图形和基于文字的警告，而主动功能则利用电子设备进行及时提醒和警报。互动功能允许患者参与包装并协助药物追踪和成瘾管理。
  • 许多公司正在积极推行新产品发布和策略伙伴关係等策略，以在不断变化的环境中保持竞争力。尤其是技术主导的药物依从性公司 Acute Technology 正在推广其 Hydra Communications Gateway。该技术可让智慧型手机使用者以电子方式监控他们的药物摄取量，从而解决管理每週托盘上分发的药物的担忧。
  • 吉利德、礼来等製药巨头正站在对抗新冠肺炎疫情的最前线。他们的股价飙升，反映出人们对创新的重新关注，特别是在感染疾病领域。由于迫切需要寻找 COVID-19 治疗方法，这种活动的增加可能会对依从性包装市场产生重大影响。总之，先进的包装和主要製药公司对 COVID-19 治疗的投资增加预计将推动依从性包装市场的显着成长。

依从性包装市场趋势

多剂量包装可望大幅成长

  • 服药依从性和同步用药的好处日益重要，刺激了多剂量包​​装解决方案的出现。多剂量泡壳卡具有多种优点，包括简化给药时间表以减少混乱、鼓励自我治疗和减少每月的药房就诊次数。大量研究表明，多剂量泡壳包装可提高药物依从性和健康结果，尤其是与药物治疗管理 (MTM) 结合时。
  • 根据印度品牌资产基金会（IBEF）的报告，印度24财年（截至2024年2月）的医药出口额预计将达到250亿美元，高于23财年的254亿美元。在全球供应链中断、停工和製造业放缓的背景下，这种韧性令人瞩目。值得注意的是，美国、比利时、南非、英国和巴西已成为印度23财年的主要出口目的地。印度的表现对全球製药业至关重要，并且表现出了坚定不移的可靠性，尤其是在经济状况不利的时候。
  • 据 IBEF 称，印度拥有在美国境外运营的符合 USFDA 要求的公司数量最多。值得注意的是，全球前20大学名药公司中有8家是印度公司，其出口产品中有一半以上（55%）销往受到严格监管的市场。作为主要的疫苗出口国，印度满足了世界卫生组织 (WHO) 65-70% 的疫苗需求。
  • Omnicell 的研究结果强调了多重药物包装对病患依从性的影响。最初，这群患者的依从率为 80%，但到研究结束时，这一比例飙升至 90%。相较之下，仅依赖锭剂的患者的药物依从性仅为 56%。 Omnicell 的解决方案 SureMed+ 是为期七天、四剂量、冷封、双折卡，在 Omnicell 向 Holyoke Health Center 提供 Multi-Med 泡壳 Card 后，Holyoke Health Center 也采用了这种卡。
  • 电子商务参与企业越来越注重便利性、合规性和增强老年人医疗保健包装。亚马逊去年收购 PillPack 证实了线上药品配送的需求不断增长，并表明人们对多药包的兴趣正在上升。随着 COVID-19 的爆发，多剂量包装至关重要，因为它旨在简化处方笺处理、最大限度地减少「接触点」并减少自我用药错误。

北美占据市场主导地位

  • 北美地区经济繁荣，人口老化，医疗体系先进。然而，各国的人口规模、卫生支出、国内生产总值（GDP）水准、医疗保险制度等存在很大差异。美国拥有先进的初级保健社区、广泛的医学和生命科学研究活动、较高的医疗保健支出强度以及庞大的製药、医疗用品和医疗设备产业，是世界上最大的黏性包装产品市场之一。
  • 此外，美国惩教机构的服药顺从性正在提高。大多数惩教机构中的囚犯都依赖外部药房处方笺。在某些情况下，药剂师可能会在现场。然而，此类人员配备通常有限，他们依赖集中地点供应药品，并依靠现场护理长或其他人来分发药物。因此，越来越需要一种减轻员工负担、管理良好的药局管理系统，以确保患者遵守用药规定。
  • 据 Parata Systems 称，服药依从性差每年平均给美国造成 3,000 亿美元的损失。袋装包装降低了医疗成本并改善了患者的治疗效果。随着条状包装在市场上变得越来越重要，患者意识的提高预计将给没有适当包装的药局带来压力。该公司已针对药局推出了 Parata PASSTM 36。 Parata Systems 是一家药房自动化系统供应商，提供包括管瓶填充、依从性包装、工作流程和患者体验解决方案，该公司推出了一款名为 PASSTM 36 的袋装包装机。
  • 该地区的公司致力于帮助人们坚持服药并改善治疗效果。为了实现这一目标，他们越来越多地与创新市场参与企业伙伴关係，特别是参与企业与药局有密切联繫的公司。透过这样做，这些公司旨在扩大其服务对象的覆盖范围。透过利用其主要包装专业知识和与药房领导的关係，这些公司准备开发提高依从性的解决方案并扩大其影响力。
  • 坚持用药对于成功的治疗结果至关重要，并且可以显着减少昂贵的住院需求。在这种情况下，数位治疗支持越来越受到关注。这种支援不仅限于传统的可穿戴感测器和应用程序，还包括连接的主要包装和输送系统以及先进的药物依从性监测。因此，合作伙伴关係和协作正在兴起，为药局提供云端基础的软体和设备。这些工具使药局能够以最少的工作流程调整快速部署依从性解决方案，从而改善患者的健康状况并开闢新的收益来源。

黏附包装产业概况

黏性包装市场呈现半静态状态，由少数重要参与企业组成。 Cardinal Health Inc.、WestRock Company、Omnicell Inc.、Parata Systems LLC 和 Keystone Folding Box Co. 等公司占据了很大市场份额。市场也出现了多种产品发布和合作。

2024年4月，製药、生物技术和化妆品行业的全球合作伙伴Gerresheimer最近与美国数位健康公司RxCap合作并收购了少数股权。透过此次合作，Gerresheimer 的子公司 Centor 将获得 RxCap 在美国药局的依从性解决方案的独家经销权。这些解决方案包括连接的管瓶封盖和云端基础的软体，并将增强 Centor 的现有产品。此举凸显了 Gerresheimer 致力于为客户提供整合包装和数位监控解决方案的承诺。

2024 年 4 月，加拿大医疗供应商 Healthmark Services Ltd.（RICHARDS Packaging Inc. 的一个部门）与 JFCRx 建立合作。此次合作使 Healthmark Services Ltd 成为 JFCRx 依从性袋包装、测试和半自动管瓶填充药局自动化设备的唯一供应商。 JFCRx 以其「分析主导的自动化」而闻名，它为药局提供即时资料洞察，以提高业务效率和盈利。该公司的旗舰产品 TruPak 整合了先进的硬体和软体，提供 RFID 智慧罐、可自订的袋子尺寸和即时补货等功能，以减少劳动力并提高安全性。

其他福利

  • Excel 格式的市场预测 (ME) 表
  • 3个月的分析师支持

目录

第一章 引言

  • 研究假设和市场定义
  • 研究范围

第二章调查方法

第三章执行摘要

第四章 市场洞察

  • 市场概览
  • 工业供应链分析
  • 产业吸引力-波特五力分析
    • 供应商的议价能力
    • 消费者议价能力
    • 新进入者的威胁
    • 替代品的威胁
    • 竞争对手之间的竞争强度
  • COVID-19 工业影响评估

第五章市场动态

  • 市场驱动因素
    • 减少药物浪费的需求日益增加
    • 违规率高
  • 市场问题
    • 自动化系统的安装和维护成本高
    • 缺乏对药物依从性包装的认识

第六章 政府监管

第七章市场区隔

  • 材料
    • 塑胶（PE、PET、PVC、PP）
    • 纸和纸板
    • 铝
  • 类型
    • 单位剂量包装
    • 多药包装
  • 包装类型
    • 泡壳
    • 小袋
    • 其他的
  • 最终用户产业
    • 药局
    • 医院
    • 其他的
  • 地区
    • 北美洲
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第八章竞争格局

  • 公司简介
    • Westrock Company
    • Keystone Folding Box Co.
    • Cardinal Health Inc.
    • Omnicell Inc.
    • Jones Healthcare Group
    • Drug Package LLC
    • Parata Systems LLC
    • Manrex Limited
    • Medicine-On-Time LLC
    • Rx Systems Inc.

第九章投资分析

第十章：市场的未来

简介目录
Product Code: 67618

The Adherence Packaging Market size is estimated at USD 1.11 billion in 2025, and is expected to reach USD 1.54 billion by 2030, at a CAGR of 6.72% during the forecast period (2025-2030).

Adherence Packaging - Market - IMG1

Key Highlights

  • Adherence packaging, predominantly utilized in healthcare, serves to streamline medication management, replacing traditional pill organizers. This packaging aligns with patients' daily routines, facilitating timely and accurate prescription intake as directed by healthcare providers.
  • Inadequate adherence to pharmacological therapy and illness management is a known factor leading to emergency hospitalizations among those with chronic obstructive pulmonary disease (COPD). Consequently, the demand for adherence packaging is on the rise, with projections indicating substantial growth in the near future.
  • Furthermore, a heightened focus on minimizing drug waste is bolstering the adherence packaging sector. Waste not only strains healthcare finances but also poses environmental risks. Yet, the industry faces challenges, notably in the form of high implementation, installation, and maintenance costs, which could potentially impede its global expansion.
  • Recent advancements in packaging technology are integrating digital capture features utilizing near-field communication (NFC) or radio frequency identification (RFID). These innovations aim to enhance verification processes. Unit-dose blisters, equipped with passive, active, and interactive elements, are at the forefront of combating the opioid crisis and bolstering pharmaceutical safety. Passive components include graphic or text-based alerts, while active features leverage electronics for timely reminders or alarms. Interactive functionalities empower patients to engage with the packaging, aiding in dose recording and addiction management.
  • Several companies are actively pursuing strategies, like new product launches and strategic partnerships, to stay competitive in this evolving landscape. Notably, Acute Technology, a company in tech-driven medication adherence, is championing the Hydra Communications Gateway. This technology could potentially allow smartphone users to monitor their dosages electronically, addressing concerns around the control of medications dispensed via weekly trays.
  • Pharmaceutical giants like Gilead and Eli Lilly are at the forefront of the battle against COVID-19. Their stocks are surging, reflecting a renewed focus on innovation, especially in infectious diseases. This heightened activity, driven by the urgent quest for COVID-19 treatments, is poised to have a substantial impact on the adherence packaging market. In conclusion, the advancements and increased investments in COVID-19 therapies by leading pharmaceutical companies are expected to drive significant growth in the adherence packaging market.

Adherence Packaging Market Trends

Multi-dose Packaging is Expected to Witness Significant Growth

  • The rising significance of medication adherence and the advantages of synchronizing medications have spurred the emergence of multi-dose packaging solutions. Multi-dose blister cards offer several benefits, such as streamlining dosage schedules to reduce confusion, facilitating self-medication, and reducing monthly pharmacy visits. Numerous studies underscore the enhanced adherence and health outcomes associated with multi-med blister packs, especially when coupled with medication therapy management (MTM).
  • As reported by the India Brand Equity Foundation (IBEF), India's drug and pharmaceutical exports in FY 2024 (until February 2024) reached USD 25.0 billion, from USD 25.4 billion recorded in FY 2023. This resilience is notable, given the backdrop of global supply chain disruptions, lockdowns, and subdued manufacturing. Notably, the United States, Belgium, South Africa, the United Kingdom, and Brazil emerged as India's primary export destinations in FY 2023. India's performance underscored its pivotal role in the global pharma landscape, showcasing unwavering reliability even in the face of crises, notably exemplified during the COVID-19 pandemic.
  • According to IBEF, India boasts the highest number of USFDA-compliant companies operating outside the United States. Notably, 8 out of the top 20 global generic companies hail from India, and more than half (55%) of the country's exports target highly regulated markets. Given its status as a major vaccine exporter, India fulfills a substantial 65-70% of the World Health Organization's (WHO) vaccine demand.
  • Findings from an Omnicell survey underscore the impact of multimed packaging on patient adherence. Initially, patients in this group achieved an 80% adherence rate, which surged to an impressive 90% by the trial's end. In contrast, patients relying solely on pill bottles managed a modest 56% adherence rate. Omnicell's solution, the SureMed+, a seven-day, four-time pass, cold-seal, bi-fold card, was adopted by Holyoke Health Center following Omnicell's provision of multimed blister cards.
  • E-commerce players are increasingly focusing on enhancing convenience, compliance, and tailored healthcare packaging for the elderly. Amazon's acquisition of PillPack last year underscores the rising demand for online medication delivery, hinting at a growing interest in multi-med packs. With the onset of COVID-19, multi-dose packaging is crucial, aiming to streamline prescription processing, minimize 'touchpoints,' and mitigate self-medication errors.

North America Dominates the Market

  • The North American region is developed with prosperous economies, aging population segments, and advanced medical delivery systems. Still, the countries vary measurably in population size, healthcare spending intensities, aggregate gross domestic product (GDP) levels, and the structure of health insurance plans. With an advanced primary medical community, extensive medical and life science research activities, high healthcare spending intensity, and large pharmaceutical and medical supply and device industries, the United States accounts for one of the world's largest geographical markets for adherence packaging products.
  • Furthermore, the United States is witnessing improved medication adherence in the correctional setting. The incarcerated population in most correctional facilities relies on an outside pharmacy to fill their prescriptions. An onsite pharmacist may be provided in some situations. However, such staff is often restricted, relying on a centralized location to supply drugs and an onsite nurse manager or similar to dispense. This strengthens the case for dispensing administration systems that are low-effort for personnel while yet being well-managed to ensure patient adherence.
  • As per Parata Systems, non-adherence to medication, on average, costs USD 300 billion/year in the United States. Pouch packaging has reduced the cost of care and improved patient outcomes. With the growing presence of strip packaging in the market, patient awareness is expected to pressure pharmacies without proper packaging to be left behind. The company launched Parata PASSTM 36, targeting pharmacies. Parata Systems, being a provider of pharmacy automation systems, including vial-filling, adherence packaging, and workflow and patient experience solutions, launched a pouch packager named PASSTM 36.
  • Businesses in the region are focused on a mission: helping people stay adherent to their medications and improving their care outcomes. To achieve this, they are increasingly forging partnerships with innovative market players, particularly those with strong ties to pharmacies. By doing so, these businesses aim to expand the reach of the patients they serve. Leveraging their expertise in primary packaging and their relationships with pharmacy leaders, these companies are poised to develop enhanced adherence solutions, thereby magnifying their impact.
  • Adherence to medication is pivotal to successful therapy outcomes and can significantly reduce the need for costly hospitalizations. In this landscape, digital therapy support is gaining prominence. This support extends beyond traditional body-worn sensors and apps, encompassing connected primary packaging, delivery systems, and advanced medication adherence monitoring. Consequently, collaborations and alliances are emerging, offering cloud-based software and devices to pharmacies. These tools empower pharmacies to swiftly introduce adherence solutions, bolstering patients' health journeys with minimal workflow adjustments and paving the way for new revenue streams.

Adherence Packaging Industry Overview

The adherence packaging market is semi-consolidated and consists of a few significant players. Companies like Cardinal Health Inc., WestRock Company, Omnicell Inc., Parata Systems LLC, and Keystone Folding Box Co. hold substantial market shares. The market is also witnessing multiple product launches and partnerships.

In April 2024, Gerresheimer, a global partner for the pharma, biotech, and cosmetics industries, recently partnered with US digital health company RxCap, acquiring a minority stake. In this collaboration, Gerresheimer's subsidiary, Centor, gains exclusive US pharmacy distribution rights for RxCap's adherence solutions. These solutions include connected prescription vial closures and cloud-based software, enhancing Centor's existing offerings. This move underscores Gerresheimer's commitment to providing customers with integrated packaging and digital monitoring solutions.

In April 2024, Canadian medical supplier Healthmark Services Ltd, a division of RICHARDS Packaging Inc., teamed up with JFCRx. This partnership designates Healthmark Services Ltd as the sole provider of JFCRx's adherence pouch packaging, inspection, and semi-automated vial filling pharmacy automation equipment. JFCRx, known for its "analytics-driven automation," empowers pharmacies with real-time data insights, enhancing operational efficiency and profitability. Their flagship product, TruPak, integrates advanced hardware and software, offering features like RFID smart canisters, customizable pouch sizes, and on-the-fly replenishment, ensuring both labor savings and enhanced safety.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 Study Assumptions and Market Definition
  • 1.2 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET INSIGHTS

  • 4.1 Market Overview
  • 4.2 Industry Supply Chain Analysis
  • 4.3 Industry Attractiveness - Porter's Five Forces Analysis
    • 4.3.1 Bargaining Power of Suppliers
    • 4.3.2 Bargaining Power of Consumers
    • 4.3.3 Threat of New Entrants
    • 4.3.4 Threat of Substitute Products
    • 4.3.5 Intensity of Competitive Rivalry
  • 4.4 Assessment of the Impact of COVID-19 on the Industry

5 MARKET DYNAMICS

  • 5.1 Market Drivers
    • 5.1.1 Rise in Need to Minimize Medication Wastage
    • 5.1.2 High Rate of Medication Non-adherence
  • 5.2 Market Challenges
    • 5.2.1 High Installation and Maintenance Costs of Automated Systems
    • 5.2.2 Lack of Awareness Regarding Medication Adherence Packaging

6 GOVERNMENT REGULATIONS

7 MARKET SEGMENTATION

  • 7.1 Material
    • 7.1.1 Plastic (PE, PET, PVC, and PP)
    • 7.1.2 Paper and Paperboard
    • 7.1.3 Aluminum
  • 7.2 Type
    • 7.2.1 Unit-dose Packaging
    • 7.2.2 Multi-dose Packaging
  • 7.3 Packaging Type
    • 7.3.1 Blisters
    • 7.3.2 Pouches
    • 7.3.3 Other Packaging Types
  • 7.4 End-user Industry
    • 7.4.1 Pharmacies
    • 7.4.2 Hospitals
    • 7.4.3 Other End-user Industries
  • 7.5 Geography
    • 7.5.1 North America
    • 7.5.2 Europe
    • 7.5.3 Asia-Pacific
    • 7.5.4 Latin America
    • 7.5.5 Middle East and Africa

8 COMPETITIVE LANDSCAPE

  • 8.1 Company Profiles
    • 8.1.1 Westrock Company
    • 8.1.2 Keystone Folding Box Co.
    • 8.1.3 Cardinal Health Inc.
    • 8.1.4 Omnicell Inc.
    • 8.1.5 Jones Healthcare Group
    • 8.1.6 Drug Package LLC
    • 8.1.7 Parata Systems LLC
    • 8.1.8 Manrex Limited
    • 8.1.9 Medicine-On-Time LLC
    • 8.1.10 Rx Systems Inc.

9 INVESTMENT ANALYSIS

10 FUTURE OF THE MARKET